Historical Stock Price
HRTX historical stock prices picture
Heron Therapeutics (HRTX) has the following price history information. Looking back at HRTX historical stock prices for the last five trading days, on March 21, 2024, HRTX opened at $2.96, traded as high as $3.20 and as low as $2.96, and closed at $3.05. Trading volume was a total of 2.01M shares. On March 22, 2024, HRTX opened at $3.04, traded as high as $3.08 and as low as $2.95, and closed at $2.97. Trading volume was a total of 1.26M shares. On March 25, 2024, HRTX opened at $2.97, traded as high as $3.08 and as low as $2.94, and closed at $2.95. Trading volume was a total of 1.31M shares. On March 26, 2024, HRTX opened at $2.98, traded as high as $3.08 and as low as $2.73, and closed at $2.74. Trading volume was a total of 1.98M shares. On March 27, 2024, HRTX opened at $2.83, traded as high as $2.83 and as low as $2.67, and closed at $2.74. Trading volume was a total of 1.22M shares.

HRTX Historical Stock Prices By Date:

HRTX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Heron Therapeutics shares, starting with a $10,000 purchase of HRTX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 03/27/2024
Start price/share: $13.91
End price/share: $2.74
Dividends collected/share: $0.00
Total return: -80.30%
Average Annual Total Return: -15.00%
Starting investment: $10,000.00
Ending investment: $1,969.62
Years: 10.00
Date Open High Low Close Volume
03/21/2024 $2.96 $3.20 $2.96 $3.05 2.01M
03/22/2024 $3.04 $3.08 $2.95 $2.97 1.26M
03/25/2024 $2.97 $3.08 $2.94 $2.95 1.31M
03/26/2024 $2.98 $3.08 $2.73 $2.74 1.98M
03/27/2024 $2.83 $2.83 $2.67 $2.74 1.22M
Heron Therapeutics is a commercial-stage biotechnology company focused on developing treatments for acute care and oncology patients. Co.'s oncology care product portfolio includes SUSTOL, which is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide combination chemotherapy regimens. Co.'s acute care product portfolio includes: ZYNRELEF, which is indicated in adults for soft tissue or periarticular instillation; and APONVIE (HTX-019), which is indicated for the prevention of postoperative nausea and vomiting in adults.
Date Close
03/21/2024$3.05
03/22/2024$2.97
03/25/2024$2.95
03/26/2024$2.74
03/27/2024$2.74
HRTX is categorized under the Healthcare sector; below are some other companies in the same sector:

HSGX Historical Stock Prices
HSIC Historical Stock Prices
HSKA Historical Stock Prices
HSM Historical Stock Prices
HSP Historical Stock Prices
HTBX Historical Stock Prices
HTGM Historical Stock Prices
HTL Historical Stock Prices
HTWR Historical Stock Prices
HWAY Historical Stock Prices

Also explore: HRTX shares outstanding history

Email EnvelopeFree HRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


HRTX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.